Cue Biopharma Balance Sheet Health
Financial Health criteria checks 5/6
Cue Biopharma has a total shareholder equity of $37.1M and total debt of $8.2M, which brings its debt-to-equity ratio to 22%. Its total assets and total liabilities are $61.5M and $24.4M respectively.
Key information
22.0%
Debt to equity ratio
US$8.17m
Debt
Interest coverage ratio | n/a |
Cash | US$48.51m |
Equity | US$37.09m |
Total liabilities | US$24.45m |
Total assets | US$61.53m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1UC's short term assets ($51.5M) exceed its short term liabilities ($17.1M).
Long Term Liabilities: 1UC's short term assets ($51.5M) exceed its long term liabilities ($7.4M).
Debt to Equity History and Analysis
Debt Level: 1UC has more cash than its total debt.
Reducing Debt: 1UC's debt to equity ratio has increased from 0% to 22% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1UC has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 1UC has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 11.6% each year.